American Renal Associates (ARA) Misses Q1 EPS by 7c

American Renal Associates (NYSE: ARA) reported Q1 EPS of ($0.29), $0.07 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $193.2 million versus the consensus estimate of $201.7 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Freedom Broker Starts Autoliv, Inc. (ALV) at Buy
• Sysco closes C$1.5 billion senior notes offering for Jetro acquisition